XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Other Working Capital Changes came in at -$753000.0 in Q1 2026, down 137.54% year-on-year from $2.0 million in Q1 2025, and down 242.34% quarter-over-quarter from $529000.0 in Q4 2025.
XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$753000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$753000.0, down 137.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 52.48% YoY), and the FY2025 annual result was -$1.3 million, up 63.31% from the prior year.
- Other Working Capital Changes came in at -$753000.0 for Q1 2026 at XOMA Royalty, down from $529000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q4 2022 to a low of -$2.4 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$217000.0 (2023), against an average of -$349529.4.
- Across the five-year window, Other Working Capital Changes jumped 249.21% in 2022 and plunged 29133.33% in 2024, its largest moves.
- XOMA Royalty's Other Working Capital Changes stood at $1.0 million in 2022, then plunged by 99.43% to $6000.0 in 2023, then slumped by 29133.33% to -$1.7 million in 2024, then jumped by 130.37% to $529000.0 in 2025, then sank by 242.34% to -$753000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$753000.0 (Q1 2026), $529000.0 (Q4 2025), and -$124000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -753,000.00 |
| Mar 31, 2026 | -753,000.00 |
| Dec 31, 2025 | 529,000.00 |
| Dec 31, 2025 | 529,000.00 |
| Sep 30, 2025 | -124,000.00 |
| Sep 30, 2025 | -124,000.00 |
| Jun 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | -317,000.00 |
| Mar 31, 2025 | -317,000.00 |
| Dec 31, 2024 | -1.74 Mn |
| Dec 31, 2024 | -1.74 Mn |
| Sep 30, 2024 | -2.43 Mn |
| Sep 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 816,000.00 |
| Mar 31, 2024 | -213,000.00 |
| Mar 31, 2024 | -213,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |